Activity-Based Protein Profiling Reveals That Cephalosporins Selectively Active on Non-replicating Mycobacterium tuberculosis Bind Multiple Protein Families and Spare Peptidoglycan Transpeptidases

• Published in: Frontiers in microbiology Vol. 11; p. 1248
• Main Authors: Lopez Quezada, Landys, Smith, Robert, Lupoli, Tania J., Edoo, Zainab, Li, Xiaojun, Gold, Ben, Roberts, Julia, Ling, Yan, Park, Sae Woong, Nguyen, Quyen, Schoenen, Frank J., Li, Kelin, Hugonnet, Jean-Emmanuel, Arthur, Michel, Sacchettini, James C., Nathan, Carl, Aubé, Jeffrey
• Format: Journal Article
• Language: English
• Published: Frontiers Media 23.06.2020; Frontiers Media S.A
• Subjects: ABPP; Biochemistry, Molecular Biology; cephalosporin; click chemistry; Life Sciences; M. tuberculosis; Microbiology; Microbiology and Parasitology; Molecular biology; non-replicating; β-lactams; β-lactams; click chemistry; non-replicating; cephalosporin; M. tuberculosis; ABPP
• ISSN: 1664-302X; 1664-302X
• DOI: 10.3389/fmicb.2020.01248

As β-lactams are reconsidered for the treatment of tuberculosis (TB), their targets are assumed to be peptidoglycan transpeptidases, as verified by adduct formation and kinetic inhibition of Mycobacterium tuberculosis (Mtb) transpeptidases by carbapenems active against replicating Mtb. Here, we investigated the targets of recently described cephalosporins that are selectively active against non-replicating (NR) Mtb. NR-active cephalosporins failed to inhibit recombinant Mtb transpeptidases. Accordingly, we used alkyne analogs of NR-active cephalosporins to pull down potential targets through unbiased activity-based protein profiling and identified over 30 protein binders. None was a transpeptidase. Several of the target candidates are plausibly related to Mtb's survival in an NR state. However, biochemical tests and studies of loss of function mutants did not identify a unique target that accounts for the bactericidal activity of these beta-lactams against NR Mtb. Instead, NR-active cephalosporins appear to kill Mtb by collective action on multiple targets. These results highlight the ability of these β-lactams to target diverse classes of proteins.As β-lactams are reconsidered for the treatment of tuberculosis (TB), their targets are assumed to be peptidoglycan transpeptidases, as verified by adduct formation and kinetic inhibition of Mycobacterium tuberculosis (Mtb) transpeptidases by carbapenems active against replicating Mtb. Here, we investigated the targets of recently described cephalosporins that are selectively active against non-replicating (NR) Mtb. NR-active cephalosporins failed to inhibit recombinant Mtb transpeptidases. Accordingly, we used alkyne analogs of NR-active cephalosporins to pull down potential targets through unbiased activity-based protein profiling and identified over 30 protein binders. None was a transpeptidase. Several of the target candidates are plausibly related to Mtb's survival in an NR state. However, biochemical tests and studies of loss of function mutants did not identify a unique target that accounts for the bactericidal activity of these beta-lactams against NR Mtb. Instead, NR-active cephalosporins appear to kill Mtb by collective action on multiple targets. These results highlight the ability of these β-lactams to target diverse classes of proteins.